Literature DB >> 8404882

Hepatitis E virus infection in pregnancy in Ethiopia.

E Tsega1, K Krawczynski, B G Hansson, E Nordenfelt.   

Abstract

Thirty-two pregnant and 34 nonpregnant Ethiopian women between 15 and 45 years of age with sporadic acute viral hepatitis were studied consecutively. Demographic data including family size, monthly income and nutritional status as well as hepatitis virus markers were compared in the pregnant and nonpregnant groups. Only 3 nonpregnant women had hepatitis A infection. Hepatitis B infection was diagnosed in 4 pregnant and 9 nonpregnant women. Nineteen (59%) pregnant women had hepatitis E virus (HEV) infection as compared to 7 (22%) in the nonpregnant group (Relative risk = 2.88; 95% Confidence interval = 1.4-5.9). The remaining 9 pregnant and 15 nonpregnant women had non-A, non-B, non-E (NANBNE) hepatitis. Of a total of 10 maternal deaths, 9 occurred (7 during the third trimester) in the pregnant group, 8 in association with HEV infection. Two deaths, one from each group, were due to NANBNE hepatitis. In addition to 6 foetal losses as a result of maternal death, there were 2 foetal deaths and 7 premature deliveries as a direct result of acute viral hepatitis, all but 2 associated with HEV infection. Comparison of socioeconomic and nutritional status, clinical features, mean aminotransferase and bilirubin levels did not show differences in the two groups. Thus, pregnant women are more at risk to acquire HEV infection than nonpregnant women and HEV infection in this group of Ethiopian pregnant women is associated with high maternal mortality and neonatal complications.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404882

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  25 in total

1.  Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells.

Authors:  Y Zhang; P McAtee; P O Yarbough; A W Tam; T Fuerst
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Hepatitis E: Epidemiology and prevention.

Authors:  Eyasu H Teshale; Dale J Hu
Journal:  World J Hepatol       Date:  2011-12-27

Review 3.  Female gender in the setting of liver transplantation.

Authors:  Kryssia Isabel Rodríguez-Castro; Eleonora De Martin; Martina Gambato; Silvia Lazzaro; Erica Villa; Patrizia Burra
Journal:  World J Transplant       Date:  2014-12-24

Review 4.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

Review 5.  An update on the hepatitis E virus.

Authors:  Seth N Sclair; Eugene R Schiff
Journal:  Curr Gastroenterol Rep       Date:  2013-02

Review 6.  Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection.

Authors:  Lisa J Krain; Jessica E Atwell; Kenrad E Nelson; Alain B Labrique
Journal:  Am J Trop Med Hyg       Date:  2014-01-13       Impact factor: 2.345

7.  An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan.

Authors:  Duria A Rayis; Ammar M Jumaa; Gasim I Gasim; Mubark S Karsany; Ishag Adam
Journal:  Pathog Glob Health       Date:  2013-03       Impact factor: 2.894

Review 8.  Hepatitis E vaccines: progress and prospects.

Authors:  Harald Claus Worm; Gerhard Wirnsberger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality.

Authors:  Bhupesh K Prusty; Suresh Hedau; Ajay Singh; Premasis Kar; Bhudev C Das
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

10.  Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana.

Authors:  Andrew A Adjei; Yao Tettey; John T Aviyase; Clement Adu-Gyamfi; Samuel Obed; Julius A A Mingle; Patrick F Ayeh-Kumi; Theophilus K Adiku
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.